TAI · 3054.TW
LIWANLI Innovation Co., Ltd.
NT$57.00-NT$0.50 (-0.87%)
LIWANLI Innovation Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.63% below the high.
Loading market information…
TWO · 4747.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Johnson Chemical Pharmaceutical Works Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Johnson Chemical Pharmaceutical Works Co., Ltd.’s forward annual dividend is NT$0.53 per share, paid annual. The forward yield is 2.29% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Johnson Chemical Pharmaceutical Works Co., Ltd., established in 1959 and headquartered in New Taipei City, Taiwan, is a Taiwanese company that engages in the manufacturing, importing, and distribution of pharmaceutical raw materials, active ingredients, and finished drug products. The company's diverse product portfolio addresses a wide spectrum of health conditions, encompassing areas such as the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine systems, alongside offerings for vitamin supplementation, anti-inflammatory needs, cough and cold remedies, and pain relief. These medicinal products are available in various forms, including traditional solid oral dosages like capsules, tablets, powders, and granules, as well as specialized delivery systems such as nasal sprays.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$57.00-NT$0.50 (-0.87%)
LIWANLI Innovation Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.63% below the high.
NT$21.00-NT$0.05 (-0.24%)
Maywufa Company Ltd.’s quoted price sits in the upper half of its reported 52-week range, 5.83% below the high.
NT$23.95-NT$0.10 (-0.42%)
Allied Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
NT$5.85-NT$0.09 (-1.52%)
Mercury Biopharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 52.05% below the high.
NT$73.00-NT$1.10 (-1.48%)
A Plus Biotechnology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
NT$11.25-NT$0.10 (-0.88%)
PhytoHealth Corporation’s quoted price sits in the lower half of its reported 52-week range, 26.23% below the high.
NT$55.70+NT$0.80 (+1.46%)
TSH Biopharm Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
NT$26.55-NT$0.05 (-0.19%)
G&E Herbal Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.88% below the high.
